Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs AmberHealth

CoreAge Rx
Graded #1Partner

Higher grade

vs+11
AmberHealth
Graded #17Editorial

Lower grade

The verdict

CoreAge Rx takes it — 94/100 to 83/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 94/100 (A).

Partner links are labeled — we may earn a commission at no cost to you. It never changes the grade.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +2
92
90
Dose & formulationCoreAge Rx +8
88
80
Clinical oversightCoreAge Rx +14
93
79
Labs & monitoringCoreAge Rx +12
90
78
FulfillmentCoreAge Rx +9
95
86
Contract termsCoreAge Rx +14
96
82
CoreAge Rx · left barAmberHealth · right bar

The numbers

MetricCoreAge RxAmberHealth
WeighScore94/10083/100
GradeAB
Scorecard rank#1#17
Semaglutide$149/mo$100/mo
Tirzepatide$349/mo$175/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
RelationshipPartnerEditorial
CoreAge Rx

Graded #1 · A

Strengths

  • Flat all-in price with no month-two step-up
  • Semaglutide and tirzepatide on one account
  • All 50 states, LegitScript-verified

Where it loses points

  • Not the cheapest sticker price
  • Compounded only
  • Pharmacy partner not yet publicly named
AmberHealth

Graded #17 · B

Strengths

  • $100 semaglutide
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Tirzepatide $175
  • Monitoring detail sparse

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard